share_log

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday

Surgery Partners公佈銷售疲軟，週一加入Kosmos Energy、Moderna和其他大股走低
Benzinga ·  02/26 11:18

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday.

美國股市小幅上漲，納斯達克綜合指數週一上漲約10點。

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) fell sharply during Monday's session following weak quarterly sales.

由於季度銷售疲軟，Surgery Partners, Inc.（納斯達克股票代碼：SGRY）的股價在週一的交易中大幅下跌。

Surgery Partners posted adjusted earnings of 44 cents per share, versus market estimates of 38 cents per share. The company's quarterly sales came in at $735.40 million missing expectations of $741.40 million, according to data from Benzinga Pro.

Surgery Partners公佈的調整後每股收益爲44美分，而市場預期的每股收益爲38美分。根據Benzinga Pro的數據，該公司的季度銷售額爲7.354億美元，未達到預期的7.414億美元。

Surgery Partners shares tumbled 7.8% to $30.43 on Monday.

週一，Surgery Partners股價下跌7.8％，至30.43美元。

Here are some other big stocks recording losses in today's session.

以下是今天交易日其他一些錄得跌幅的大型股票。

  • Intuitive Machines, Inc. (NASDAQ:LUNR) dipped 25.1% to $7.18 after the company said its lunar lander may have tipped over upon landing on the moon.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 11.3% to $15.29. Nyxoah is expected to release fourth quarter financial results on March 5, 2024.
  • Jin Medical International Ltd. (NASDAQ:ZJYL) fell 11.2% to $6.30.
  • TransMedics Group, Inc. (NASDAQ:TMDX) dipped 8.6% to $75.99. TransMedics Group is expected to release financial results for the fourth quarter after market close on Feb. 26, 2024.
  • World Acceptance Corporation (NASDAQ:WRLD) declined 7% to $120.71. World Acceptance recently reported better-than-expected third-quarter financial results.
  • MacroGenics, Inc. (NASDAQ:MGNX) fell 7% to $16.88.
  • Kosmos Energy Ltd. (NYSE:KOS) dipped 7% to $5.55. Kosmos Energy reported a fourth-quarter fiscal 2023 revenue decline of 10% year-over-year to $507.81 million, beating the consensus of $477.73 million.
  • Orla Mining Ltd. (NASDAQ:ORLA) fell 6.8% to $3.38.
  • Insulet Corporation (NASDAQ:PODD) fell 5.8% to $173.54 after Barclays maintained an Equal-Weight rating on the stock and lowered its price target from $214 to $213.
  • Summit Therapeutics Inc. (NASDAQ:SMMT) declined 5.6% to $4.38.
  • Moderna, Inc. (NASDAQ:MRNA) fell 4.3% to $92.36 after HSBC downgraded the stock from Hold to Reduce but raised its price target from $75 to $86.
  • Intuitive Machines, Inc.（納斯達克股票代碼：LUNR）下跌25.1％，至7.18美元，此前該公司表示，其月球着陸器可能在登陸月球時翻倒。
  • Nyxoah S.A.（納斯達克股票代碼：NYXH）下跌11.3％，至15.29美元。預計Nyxoah將於2024年3月5日發佈第四季度財務業績。
  • 金醫療國際有限公司（納斯達克股票代碼：ZJYL）下跌11.2％，至6.30美元。
  • TransMedics集團公司（納斯達克股票代碼：TMDX）下跌8.6％，至75.99美元。預計TransMedics集團將在2024年2月26日收盤後發佈第四季度的財務業績。
  • 世界認可公司（納斯達克股票代碼：WRLD）下跌7％，至120.71美元。World Acceptance最近公佈的第三季度財務業績好於預期。
  • MacroGenics, Inc.（納斯達克股票代碼：MGNX）下跌7％，至16.88美元。
  • 科斯莫斯能源有限公司（紐約證券交易所代碼：KOS）下跌7％，至5.55美元。Kosmos Energy報告稱，2023財年第四季度收入同比下降10％，至5.0781億美元，超過了預期的4.7773億美元。
  • 奧拉礦業有限公司（納斯達克股票代碼：ORLA）下跌6.8％，至3.38美元。
  • Insulet Corporation（納斯達克股票代碼：PODD）下跌5.8％，至173.54美元，此前巴克萊維持該股的同等權重評級，並將其目標股價從214美元下調至213美元。
  • Summit Therapeutics Inc.（納斯達克股票代碼：SMMT）下跌5.6％，至4.38美元。
  • 摩德納公司（納斯達克股票代碼：MRNA）下跌4.3％，至92.36美元，此前匯豐銀行將該股的評級從持有下調至減持，但將目標股價從75美元上調至86美元。

Now Read This: Top 3 Defensive Stocks That May Collapse In February

現在讀這個： 二月份可能暴跌的三大防禦性股票

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論